Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, Rahbar H, Sung JS, Jacobs C, Harvey JA, Nicholson MH, Ward RC, Holt J, Prather A, Miller KD, Schnall MD, Kuhl CK. Comstock CE, et al. Among authors: newstead gm. JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572. JAMA. 2020. PMID: 32096852 Free PMC article. Clinical Trial.
MR imaging of the breast.
Weinreb JC, Newstead G. Weinreb JC, et al. Radiology. 1995 Sep;196(3):593-610. doi: 10.1148/radiology.196.3.7644617. Radiology. 1995. PMID: 7644617 Review.
Controversies in breast MRI.
Weinreb JC, Newstead G. Weinreb JC, et al. Magn Reson Q. 1994 Jun;10(2):67-83. Magn Reson Q. 1994. PMID: 7986702 Review.
When and when not to biopsy the breast.
Newstead G. Newstead G. Diagn Imaging (San Franc). 1993 Mar;15(3):111, 115-6. Diagn Imaging (San Franc). 1993. PMID: 10148387 No abstract available.
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators. Hylton NM, et al. Among authors: newstead gm. Radiology. 2012 Jun;263(3):663-72. doi: 10.1148/radiol.12110748. Radiology. 2012. PMID: 22623692 Free PMC article.
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.
Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators. Hylton NM, et al. Among authors: newstead gm. Radiology. 2016 Apr;279(1):44-55. doi: 10.1148/radiol.2015150013. Epub 2015 Dec 1. Radiology. 2016. PMID: 26624971 Free PMC article.
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.
Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM; ACRIN Trial team ISPY-1 Investigators. Bolan PJ, et al. Among authors: newstead gm. J Magn Reson Imaging. 2017 Jul;46(1):290-302. doi: 10.1002/jmri.25560. Epub 2016 Dec 16. J Magn Reson Imaging. 2017. PMID: 27981651 Free PMC article. Clinical Trial.
83 results